Jpmorgan Chase & CO Immutep LTD Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Immutep LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,753 shares of IMMP stock, worth $3,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,753Holding current value
$3,295% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding IMMP
# of Institutions
27Shares Held
2.28MCall Options Held
6.7KPut Options Held
114K-
Black Rock Inc. New York, NY749KShares$1.41 Million0.0% of portfolio
-
Oracle Investment Management Inc Greenwich, CT565KShares$1.06 Million1.83% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny349KShares$656,9860.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA173KShares$324,8650.0% of portfolio
-
Caption Management, LLC Oklahoma City, OK73.3KShares$137,7880.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $163M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...